Evidence map›Paper›PMID 35628748›Full record

ArticleJournal of fungi (Basel, Switzerland)2022

Four New Highly Oxygenated Eremophilane Sesquiterpenes from an Endophytic Fungus

Hong-Lian Ai, Xiao Lv, Ke Ye, Meng-Xi Wang, Rong Huang, Bao-Bao Shi, Zheng-Hui Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hong-Lian AiSchool of Pharmaceutical Sciences, South-Central MinZu University, Wuhan 430074, China.
Xiao LvSchool of Pharmaceutical Sciences, South-Central MinZu University, Wuhan 430074, China.
Ke YeSchool of Pharmaceutical Sciences, South-Central MinZu University, Wuhan 430074, China.
Meng-Xi WangSchool of Pharmaceutical Sciences, South-Central MinZu University, Wuhan 430074, China.
Rong HuangSchool of Pharmaceutical Sciences, South-Central MinZu University, Wuhan 430074, China.
Bao-Bao ShiSchool of Pharmaceutical Sciences, South-Central MinZu University, Wuhan 430074, China.
Zheng-Hui LiSchool of Pharmaceutical Sciences, South-Central MinZu University, Wuhan 430074, China.
Minzu University of China · CN

Funding

Fundamental Research Funds for the Central Universities, South-Central MinZu University CZD21003National Natural Science Foundation of China 31870513
6 · The paper itself

Abstract

Four new eremophilane-type sesquiterpenes, boeremialanes A-D (

Indexed as

anti-inflammatoryBoeremia exiguaboeremialaneseremophilanesFritillaria hupehensisNO production inhibition

Identifiers

PMID35628748
PMCPMC9146970
OpenAlexW4229370154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.